Company / Operating Cash Flow per Share
Minerva Neurosciences, Inc. Operating Cash Flow per Share History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$2.80
FY2024
5-year range
-$4.62 / -$0.79
FY2020-FY2024
Trend
+39.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share returned to growth in FY2024 after 2 years of decline, reaching $-2.80.
Based on SEC 10-K filings.
-2.80 in FY2024.
Improved from $-4.61 to $-2.80 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating cash flow per share increased 39.4% year-over-year.
- Peak operating cash flow per share was recorded in FY2018.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$2.80 | +39.4% |
| FY2023 | -$4.62 | -0.2% |
| FY2022 | -$4.61 | -481.9% |
| FY2021 | -$0.79 | +28.8% |
| FY2020 | -$1.11 | -3.2% |
| FY2019 | -$1.08 | -1449.5% |
| FY2018 | $0.08 | +111.5% |
| FY2017 | -$0.69 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026